Proactive Investors - Run By Investors For Investors

Humanigen has gleaned 'significant' interest from potential partners from its data presentation

Humanigen Inc (OTCQB:HGEN) CEO Cameron Durrant caught up with Proactive Investors at the BIO CEO & Investor Conference in New York.

Durrant says the company has gleaned 'significant' interest from potential partners as a result of data presentation of its therapy lenzilumab.

 
View full HGEN profile View Profile

Humanigen Inc Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use